Viemed Healthcare (NASDAQ:VMD) Downgraded to Buy Rating by Wall Street Zen

Wall Street Zen lowered shares of Viemed Healthcare (NASDAQ:VMD) from a strong-buy rating to a buy rating in a report issued on Saturday morning.

Other analysts also recently issued research reports about the company. Freedom Capital downgraded Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 5th. Weiss Ratings raised Viemed Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, August 3rd. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold”.

Viemed Healthcare Price Performance

NASDAQ VMD opened at $9.20 on Friday. Viemed Healthcare has a 12 month low of $6.05 and a 12 month high of $12.61. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.13 and a quick ratio of 1.02. The firm has a market capitalization of $350.43 million, a PE ratio of 25.56 and a beta of 1.10. The company’s 50 day simple moving average is $11.10 and its 200 day simple moving average is $9.81.

Viemed Healthcare (NASDAQ:VMD) last released its earnings results on Monday, August 3rd. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.05). The firm had revenue of $78.10 million during the quarter, compared to analyst estimates of $78.00 million. Viemed Healthcare had a return on equity of 10.16% and a net margin of 4.81%. As a group, equities research analysts forecast that Viemed Healthcare will post 0.42 EPS for the current fiscal year.

Insider Activity at Viemed Healthcare

In other Viemed Healthcare news, Director Timothy Smokoff sold 20,000 shares of Viemed Healthcare stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total value of $230,000.00. Following the transaction, the director owned 75,518 shares in the company, valued at approximately $868,457. The trade was a 20.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider William Frazier sold 10,000 shares of the company’s stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $11.72, for a total value of $117,200.00. Following the completion of the transaction, the insider directly owned 73,214 shares in the company, valued at $858,068.08. This represents a 12.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 20.60% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Viemed Healthcare

Several large investors have recently modified their holdings of VMD. North Star Investment Management Corp. purchased a new position in Viemed Healthcare in the 1st quarter worth about $921,000. Arrowstreet Capital Limited Partnership lifted its stake in Viemed Healthcare by 101.9% during the first quarter. Arrowstreet Capital Limited Partnership now owns 711,186 shares of the company’s stock valued at $6,550,000 after buying an additional 358,863 shares in the last quarter. Lazard Asset Management LLC lifted its stake in Viemed Healthcare by 117.6% during the first quarter. Lazard Asset Management LLC now owns 215,938 shares of the company’s stock valued at $1,989,000 after buying an additional 116,700 shares in the last quarter. Hillsdale Investment Management Inc. acquired a new position in shares of Viemed Healthcare in the first quarter worth about $1,834,000. Finally, Expect Equity LLC boosted its holdings in shares of Viemed Healthcare by 59.6% in the fourth quarter. Expect Equity LLC now owns 173,970 shares of the company’s stock worth $1,293,000 after buying an additional 64,961 shares during the period. 74.24% of the stock is owned by institutional investors.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.